Expression and regulation of transcript for the novel transmembrane protein Tmem182 in the adipocyte and muscle lineage
© Wu and Smas; licensee BioMed Central Ltd. 2008
Received: 06 April 2008
Accepted: 19 September 2008
Published: 19 September 2008
White adipose tissue is not only an energy storage organ; it also functions as an endocrine organ. The coordination and integration of numerous gene expression events is required to establish and maintain the adipocyte phenotype.
We previously observed a 45-fold upregulation for a transcript encoding a novel predicted transmembrane protein, Tmem182, upon brown preadipocyte to adipocyte conversion. Here we use real-time PCR analysis to further characterize Tmem182 transcript expression in the adipocyte lineage. Analysis across a panel of 10 murine tissues revealed highest Tmem182 transcript expression in white adipose tissues (WAT), with 10-fold to 20-fold higher levels than in brown adipose tissue (BAT). Tmem182 transcript expression is ~3-fold upregulated in BAT of genetically obese (ob/ob) mice vs. wild type C57BL/6. Analysis of three in vitro models of white adipogenesis indicates markedly enriched expression of Tmem182 transcript in adipocytes vs. preadipocytes. Compared to 3T3-L1 preadipocytes, a 157-fold higher level of Tmem182 transcript is detected at 3 day post-induction of adipogenesis and an ~2500-fold higher level in mature 3T3-L1 adipocytes. TNFα treatment of 3T3-L1 adipocytes resulted in a ~90% decrease in Tmem182 transcript level. As skeletal muscle and heart were also found to express Tmem182 transcript, we assessed expression in C2C12 myogenesis and observed a ~770-fold upregulation upon conversion of myoblasts to myocytes.
WAT is the most prominent site of Tmem182 transcript expression and levels of transcript for Tmem182 are altered in adipose tissues of ob/ob mice and upon exposure of 3T3-L1 adipocytes to the proinflammatory cytokine TNFα. The dramatic upregulation of Tmem182 transcript during in vitro adipogenesis and myogenesis suggests Tmem182 may function in intracellular pathways important in these two cell types.
White adipose tissue (WAT) is the major site for storage of excess energy and these triglyceride stores are mobilized to meet the energy needs of the organism. Adipose tissue is now also recognized as an endocrine organ with synthesis and secretion of a variety of soluble factors such as leptin, resistin, adiponectin, retinol binding protein-4 and TNFα [1–4]. Adipocytes make up from one-third to two-thirds of the cell population found in adipose tissue, with endothelial cells, nerve cells, macrophages, fibroblast-like interstitial cells and preadipocytes, and perhaps other cell types, comprising the remaining stromal-vascular component . Mature adipocytes form as the result of the differentiation of preadipocyte precursors present in adipose tissue [6–10]. Established preadipocyte cell lines such as 3T3-L1  have been an extensively used in vitro model to define genes central to the adipocyte phenotype [12, 13]. Adipogenesis is accompanied by increased transcription of genes that encode proteins key to adipocyte function, for example lipogenesis, lipolysis, lipid transport, and hormone responsiveness [7, 14, 15]. In vitro and in vivo studies have uncovered a pivotal role for peroxisome proliferator-activated receptor γ (PPARγ), a member of the ligand-activated steroid hormone receptor family, in the adipogenic program [8, 10, 16–19]. Studies have also illustrated the important contributions of the CCAAT/enhancer-binding proteins (C/EBPs) and other transcriptional signals to adipogenesis [8, 10, 20].
Culture of cell lines and adipogenic conversion for 3T3-L1, ScAP-23 and wt-BAT, for the fractionation of adipose tissues, and for culture and differentiation of murine preadipocytes from subcutaneous (SC) WAT was as described [21, 22]. C2C12 cells were maintained and passaged as subconfluent cultures in DMEM with10% FBS. For differentiation, cultures at 70% confluence were switched to DMEM with 2% horse serum and 10 μg/ml insulin, and were cultured under these conditions for 7 days. For treatment of 3T3-L1 adipocytes with TNFα and various pharmacological inhibitors the method was as described [23–25]. After serum-starvation for 6 h, 3T3-L1 adipocytes were pretreated with either 50 μM LY294002, 50 μM PD98059, 20 μM SB203580, 100 nM wortmannin, 1 μM rapamycin (Sigma-Aldrich, St. Louis, MO), or DMSO vehicle for 1 h and then cultured in 10 ng/ml of TNFα for 16 h in the presence of inhibitors. RNA was purified using TriZol Reagent (Invitrogen Corp.) according to manufacturer's instruction. For studies of Tmem182 transcript expression in murine tissues, 8 wk old C57BL/6 or ob/ob male mice were utilized, with all animal treatments conducted with approval of the University of Toledo Health Science Campus Institutional Animal Care and Use Committee.
Real-time PCR analysis was as previously described [23, 24, 26]. For this, total RNA was subject to purification with an RNeasy RNA purification kit with DNase I treatment (Qiagen Corp., Valencia, CA) and 5 μg used for first strand cDNA synthesis with SuperScript II RNase H-reverse transcriptase (Invitrogen Corp.) and an oligo(dT)-22 primer. Real time PCR was conducted with an ABI 7500 Real Time PCR System. Target cDNA levels were analyzed by SYBR green-based real-time PCR in 25 μl reactions containing 1× SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA), 100 nM each forward and reverse primers, and 10 ng of cDNA. Analyses were performed in triplicate and expression of each gene was normalized against Gapdh transcript level. The cycle threshold value was generated using ABI PRISM 7500 SDS software version 1.2 and exported to an Excel spreadsheet to calculate fold differences. Sequence of PCR primers used were: Tmem182 (5'-ACACCAATCAGCCACCATCC-3' and 5'-GCCACGGTAAATAATTGCGGAG-3'); Gapdh (5'-GGCAAATTCAACGGCACAG-3' and 5'-CGGAGATGATGACCCTTTTG-3'); and Myogenin (5'-GCCATCCAGTACATTGAGC-3'and 5'-GTAAGGGAGTGCAGATTGTG-3'). Primers were designed to span introns.
Properties of Tmem182 gene and sequence
Tissue distribution of Tmem182 transcript expression
To begin to address the modulation of Tmem182 transcript levels in regard to the pathophysiology of adipocytes, we compared transcript expression in BAT and WAT from wild type C57BL/6 mice and ob/ob mice, the latter a well-studied murine model of genetic obesity. For Tmem182 transcript, we find a slight increase (~1.7-fold, p < 0.001) in ob/ob WAT for the SC depot (Figure 2C). Furthermore, compared to wt BAT, we find a 6.3-fold upregulation (p < 0.001) of Tmem182 transcript level in ob/ob vs. wt BAT, suggestive of a role for dysregulation of Tmem182 in the obese state (Figure 2C). It would thus appear that in the ob/ob genetic model, BAT shifts to a level of Tmem182 transcript expression that is more similar to that found in WAT.
Differentiation-dependent expression of Tmem182 transcript in adipogenesis
Regulation of Tmem182 transcript by TNFα
Differentiation-dependent expression of Tmem182 transcript in myogenesis
The primary amino acid sequence of Tmem182 predicts an evolutionarily conserved novel transmembrane protein. Tmem182 protein sequence lacks homologies with previously defined protein families and Tmem182 function is currently unknown. Enrichment of Tmem182 transcript in WAT, alteration in obesity, differentiation-dependent upregulation in adipogenesis and regulation by TNFα suggests that expression of Tmem182 may be integral to the adipocyte phenotype. Interestingly, Tmem182 transcript is also enriched in muscle tissue and it is markedly upregulated during in vitro myogenesis of C2C12 myoblasts to myocytes. This suggests Tmem182 may function in cellular pathways shared by adipocytes and myocytes but not by their respective precursor cell types. Future studies will further examine the in vitro and in vivo regulation and the function of Tmem182 in adipocytes and muscle cells.
Polymerase chain reaction
Fetal bovine serum
White adipose tissue
Brown adipose tissue
Peroxisome proliferator-activated receptor
CCAAT/Enhancer binding protein
We thank Dr. J.Y. Kim for kindly providing adipocyte RNA samples.
- Coppack SW: Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001, 60: 349-356.View ArticlePubMedGoogle Scholar
- Scherer PE: Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006, 55: 1537-1545. 10.2337/db06-0263.View ArticlePubMedGoogle Scholar
- Trujillo ME, Scherer PE: Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006, 27: 762-778.View ArticlePubMedGoogle Scholar
- Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005, 436: 356-362. 10.1038/nature03711.View ArticlePubMedGoogle Scholar
- Ailhaud G, Grimaldi P, Negrel R: Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr. 1992, 12: 207-233. 10.1146/annurev.nu.12.070192.001231.View ArticlePubMedGoogle Scholar
- MacDougald OA, Mandrup S: Adipogenesis: forces that tip the scales. Trends Endocrinol Metab. 2002, 13: 5-11. 10.1016/S1043-2760(01)00517-3.View ArticlePubMedGoogle Scholar
- Gregoire FM: Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med (Maywood). 2001, 226: 997-1002.Google Scholar
- Rosen ED, MacDougald OA: Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol. 2006, 7: 885-896. 10.1038/nrm2066.View ArticlePubMedGoogle Scholar
- Ailhaud G: Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome. C R Biol. 2006, 329: 570-577. 10.1016/j.crvi.2005.12.012.View ArticlePubMedGoogle Scholar
- Rosen ED: The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids. 2005, 73: 31-34. 10.1016/j.plefa.2005.04.004.View ArticlePubMedGoogle Scholar
- Green H, Kehinde O: An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 1975, 5: 19-27. 10.1016/0092-8674(75)90087-2.View ArticlePubMedGoogle Scholar
- Ross SE, Erickson RL, Gerin I, DeRose PM, Bajnok L, Longo KA, Misek DE, Kuick R, Hanash SM, Atkins KB, Andresen SM, Nebb HI, Madsen L, Kristiansen K, MacDougald OA: Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol. 2002, 22: 5989-5999. 10.1128/MCB.22.16.5989-5999.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM: Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem. 2001, 276: 34167-34174. 10.1074/jbc.M104421200.View ArticlePubMedGoogle Scholar
- Gregoire FM, Smas CM, Sul HS: Understanding adipocyte differentiation. Physiol Rev. 1998, 78: 783-809.PubMedGoogle Scholar
- Rajala MW, Scherer PE: Minireview: The adipocyte – at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003, 144: 3765-3773. 10.1210/en.2003-0580.View ArticlePubMedGoogle Scholar
- Mueller E, Drori S, Aiyer A, Yie J, Sarraf P, Chen H, Hauser S, Rosen ED, Ge K, Roeder RG, Spiegelman BM: Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J Biol Chem. 2002, 277: 41925-41930. 10.1074/jbc.M206950200.View ArticlePubMedGoogle Scholar
- Lazar MA: PPAR gamma, 10 years later. Biochimie. 2005, 87: 9-13. 10.1016/j.biochi.2004.10.021.View ArticlePubMedGoogle Scholar
- Wu Z, Rosen ED, Brun R, Hauser S, Adelmant G, Troy AE, McKeon C, Darlington GJ, Spiegelman BM: Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell. 1999, 3: 151-158. 10.1016/S1097-2765(00)80306-8.View ArticlePubMedGoogle Scholar
- Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 1995, 83: 803-812. 10.1016/0092-8674(95)90193-0.View ArticlePubMedGoogle Scholar
- Farmer SR: Transcriptional control of adipocyte formation. Cell Metab. 2006, 4: 263-273. 10.1016/j.cmet.2006.07.001.PubMed CentralView ArticlePubMedGoogle Scholar
- Kim JY, Tillison K, Smas CM: Cloning, expression, and differentiation-dependent regulation of SMAF1 in adipogenesis. Biochem Biophys Res Commun. 2005, 326: 36-44. 10.1016/j.bbrc.2004.10.200.View ArticlePubMedGoogle Scholar
- Kim JY, Tillison K, Lee JH, Rearick DA, Smas C: The Adipose Tissue Triglyceride Lipase ATGL/PNPLA2 is Downregulated by Insulin and TNFalpha in 3T3-L1 Adipocytes and is a Target for Transactivation by PPARgamma. Am J Physiol Endocrinol Metab. 2006, 16: 16-Google Scholar
- Kim JY, Liu K, Zhou S, Tillison K, Wu Y, Smas CM: Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death. Am J Physiol Endocrinol Metab. 2008, 294: E654-667. 10.1152/ajpendo.00104.2007.View ArticlePubMedGoogle Scholar
- Wu Y, Smas CM: Wdnm1-like, a new adipokine with a role in MMP-2 activation. Am J Physiol Endocrinol Metab. 2008, 295: E205-215. 10.1152/ajpendo.90316.2008.PubMed CentralView ArticlePubMedGoogle Scholar
- Kim JY, Liu K, Zhou S, Tillison K, Wu Y, Smas CM: Assessment of Fat Specific Protein 27 (Fsp27) in the Adipocyte Lineage Suggests a Dual Role for Fsp27 in Adipocyte Metabolism and Cell Death. Am J Physiol Endocrinol Metab. 2008, 294 (4):
- Kim JY, Wu Y, Smas CM: Characterization of ScAP-23, a new cell line from murine subcutaneous adipose tissue, identifies genes for the molecular definition of preadipocytes. Physiol Genomics. 2007, 31: 328-342. 10.1152/physiolgenomics.00206.2006.View ArticlePubMedGoogle Scholar
- Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF: Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes. 2002, 51: 1319-1336. 10.2337/diabetes.51.5.1319.View ArticlePubMedGoogle Scholar
- Ruan H, Miles PD, Ladd CM, Ross K, Golub TR, Olefsky JM, Lodish HF: Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance. Diabetes. 2002, 51: 3176-3188. 10.2337/diabetes.51.11.3176.View ArticlePubMedGoogle Scholar
- Hotamisligil GS: Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord. 2000, 24 (Suppl 4): S23-27.View ArticlePubMedGoogle Scholar
- Sethi JK, Hotamisligil GS: The role of TNF alpha in adipocyte metabolism. Semin Cell Dev Biol. 1999, 10: 19-29. 10.1006/scdb.1998.0273.View ArticlePubMedGoogle Scholar
- Wellen KE, Uysal KT, Wiesbrock S, Yang Q, Chen H, Hotamisligil GS: Interaction of tumor necrosis factor-alpha- and thiazolidinedione-regulated pathways in obesity. Endocrinology. 2004, 145: 2214-2220. 10.1210/en.2003-1580.View ArticlePubMedGoogle Scholar
- Souza SC, Palmer HJ, Kang YH, Yamamoto MT, Muliro KV, Paulson KE, Greenberg AS: TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes. J Cell Biochem. 2003, 89: 1077-1086. 10.1002/jcb.10565.View ArticlePubMedGoogle Scholar
- Beutler B, Mahoney J, Le Trang N, Pekala P, Cerami A: Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med. 1985, 161: 984-995. 10.1084/jem.161.5.984.View ArticlePubMedGoogle Scholar
- Torti FM, Dieckmann B, Beutler B, Cerami A, Ringold GM: A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science. 1985, 229: 867-869. 10.1126/science.3839597.View ArticlePubMedGoogle Scholar
- Xing H, Northrop JP, Grove JR, Kilpatrick KE, Su JL, Ringold GM: TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression. Endocrinology. 1997, 138: 2776-2783. 10.1210/en.138.7.2776.PubMedGoogle Scholar
- Jain R, Police S, Phelps K, Pekala PH: Tumour necrosis factor-alpha regulates expression of the CCAAT-enhancer-binding proteins (C/EBPs) alpha and beta and determines the occupation of the C/EBP site in the promoter of the insulin-responsive glucose-transporter gene in 3T3-L1 adipocytes. Biochem J. 1999, 338 (Pt 3): 737-743. 10.1042/0264-6021:3380737.PubMed CentralView ArticlePubMedGoogle Scholar
- Stephens JM, Pekala PH: Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. J Biol Chem. 1992, 267: 13580-13584.PubMedGoogle Scholar
- Pandey M, Loskutoff DJ, Samad F: Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes. Faseb J. 2005, 19: 1317-1319.PubMedGoogle Scholar
- Trujillo ME, Lee MJ, Sullivan S, Feng J, Schneider SH, Greenberg AS, Fried SK: Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein kinase. J Clin Endocrinol Metab. 2006, 91: 1484-1490. 10.1210/jc.2005-1901.View ArticlePubMedGoogle Scholar
- Kim JY, Tillison K, Lee JH, Rearick DA, Smas CM: The adipose tissue triglyceride lipase ATGL/PNPLA2 is downregulated by insulin and TNF-alpha in 3T3-L1 adipocytes and is a target for transactivation by PPARgamma. Am J Physiol Endocrinol Metab. 2006, 291: E115-127. 10.1152/ajpendo.00317.2005.View ArticlePubMedGoogle Scholar
- Otto TC, Lane MD: Adipose development: from stem cell to adipocyte. Crit Rev Biochem Mol Biol. 2005, 40: 229-242. 10.1080/10409230591008189.View ArticlePubMedGoogle Scholar
- Kuninger D, Kuzmickas R, Peng B, Pintar JE, Rotwein P: Gene discovery by microarray: identification of novel genes induced during growth factor-mediated muscle cell survival and differentiation. Genomics. 2004, 84: 876-889. 10.1016/j.ygeno.2004.07.013.View ArticlePubMedGoogle Scholar
- Andres V, Walsh K: Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol. 1996, 132: 657-666. 10.1083/jcb.132.4.657.View ArticlePubMedGoogle Scholar
- Pownall ME, Gustafsson MK, Emerson CP: Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu Rev Cell Dev Biol. 2002, 18: 747-783. 10.1146/annurev.cellbio.18.012502.105758.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.